Winners Announced for Annual Yale Cancer Center Conclave Awards
Yale Cancer Center held its annual Conclave award ceremony virtually on January 26th to celebrate faculty and provider accomplishments 2020. Faculty and staff were honored with clinical and research prizes including the Ruth McCorkle Oncology Advanced Practice Provider Award, the Class of ‘61 Cancer Research Award, and the Yale Cancer Center Lifetime Achievement Award.
Morgan Levine receives Nathan Shock New Investigator Award from the Gerontologic Society of America.
Morgan Levine receives Nathan Shock New Investigator Award from the Gerontologic Society of America. This award recognizes outstanding contributions to new knowledge about aging through basic biological research.Source: Gerontologic Society of America
Yale Scientists Breach Brain Barriers to Attack Tumors
The brain is a sort of fortress, equipped with barriers designed to keep out dangerous pathogens. But protection comes at a cost: These barriers interfere with the immune system when faced with dire threats such glioblastoma, a deadly brain tumor for which there are few effective treatments.
Experimental drug that targets liver fat may help prevent diabetes
An experimental drug has reversed the build-up of fat in the liver and lowered blood levels of fatty substances including cholesterol in non-human primates. The build-up of fat in the liver, known as non-alcoholic fatty liver disease, affects 1 in 3 people and can lead to type 2 diabetes as well as heart and kidney disease.Source: NewScientist
Low mobility predicts hospital readmission in older heart attack patients
Close to 20% of elderly adults who have suffered a heart attack will be readmitted to the hospital within 30 days. Performance on a simple mobility test is the best predictor of whether an elderly heart attack patient will be readmitted, a Yale-led study reports.
You have two ages, chronological and biological. Here's why it matters
Essentially, everyone has two ages: a chronological age, how old the calendar says you are, and a phenotypic or biological age, basically the age at which your body functions as it compares to average fitness or health levels. Levine and her team identified nine biomarkers taken in a simple blood test that seemed to be the most influential on lifespan. The biomarkers include blood sugar, kidney and liver measures, and immune and inflammatory measures. Levine plugs those numbers into the computer, and the algorithm does the rest. People with a biological age lower than their chronological age have a lower mortality risk, while those aging older from a biological standpoint have a higher mortality risk and are potentially more prone to developing the diseases associated with the higher age range.Source: CNN
Vishwa Deep Dixit appointed the Von Zedtwitz Professor of Comparative Medicine
Vishwa Deep Dixit, newly named as the Waldemar Von Zedtwitz Professor of Comparative Medicine, studies the interaction between immune and metabolic systems with the goal of revealing targets that can be harnessed to extend the healthspan — the period of life that is free of disabilities and disease.
Yale center dedicated to research on older adults receives renewed funding
For the fifth consecutive time, the Yale Claude D. Pepper Older Americans Independence Center (OAIC) has been renewed for funding from the National Institute on Aging (NIA). The Center is one of only two such programs nationwide to receive continuous NIA support since it was first funded in 1992, marking more than 25 years of excellence in geriatrics and aging research under the leadership of Geriatrics Section Chief Dr. Mary Tinetti, Dr. Thomas Gill, and Dr. Terri Fried.